No­vavax grabs an­oth­er CFO while Pat Cotro­neo re­tires from Fi­bro­Gen; Eli Lil­ly re­assem­bles key staff af­ter bio­med­i­cines unit split

→ The peren­ni­al Char­lie Brown of vac­cine de­vel­op­ment, No­vavax is grap­pling with Lucy’s knack for pulling the foot­ball away once again, this time with its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.